Literature DB >> 28075484

Assay for Transposase-Accessible Chromatin Using Sequencing (ATAC-seq) Data Analysis.

Kristy L S Miskimen1, E Ricky Chan2, Jonathan L Haines1,2.   

Abstract

The study of epigenetic properties of the human genome, including structural modifications of DNA and chromatin, has increased tremendously as mounting evidence has demonstrated how much epigenetics affects human gene expression. Buenrostro et al. have developed a rapid method, requiring low numbers of living cells as input, for examining chromatin accessibility across the epigenome, known as the assay for transposase-accessible chromatin using sequencing (ATAC-seq). The overall goal of this unit is to provide a thorough ATAC-seq data analysis plan, as well as describe how primary human blood samples can be processed for use in ATAC-seq. In addition, a number of quality control parameters are discussed to ensure the integrity and confidence in the ATAC-seq data. © 2017 by John Wiley & Sons, Inc.
Copyright © 2017 John Wiley & Sons, Inc.

Entities:  

Keywords:  ATAC-seq; chromatin accessibility; epigenetics; peak-calling

Mesh:

Substances:

Year:  2017        PMID: 28075484     DOI: 10.1002/cphg.32

Source DB:  PubMed          Journal:  Curr Protoc Hum Genet        ISSN: 1934-8258


  3 in total

Review 1.  Detect accessible chromatin using ATAC-sequencing, from principle to applications.

Authors:  Yuanyuan Sun; Nan Miao; Tao Sun
Journal:  Hereditas       Date:  2019-08-15       Impact factor: 3.271

Review 2.  From reads to insight: a hitchhiker's guide to ATAC-seq data analysis.

Authors:  Feng Yan; David R Powell; David J Curtis; Nicholas C Wong
Journal:  Genome Biol       Date:  2020-02-03       Impact factor: 13.583

3.  JunB defines functional and structural integrity of the epidermo-pilosebaceous unit in the skin.

Authors:  Karmveer Singh; Emanuela Camera; Linda Krug; Abhijit Basu; Rajeev Kumar Pandey; Saira Munir; Meinhard Wlaschek; Stefan Kochanek; Marina Schorpp-Kistner; Mauro Picardo; Peter Angel; Catherin Niemann; Pallab Maity; Karin Scharffetter-Kochanek
Journal:  Nat Commun       Date:  2018-08-24       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.